Honeybell Pharma Private Limited
About Honeybell Pharma Private Limited
Data last updated:
Honeybell Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC316948. Its GSTIN is 27AAECH7108M1ZB (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Bhavesh Prakash Jain and Ankit Kumar Lalit Kumar Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 82/90 Ground Floor Anandbhavan Kalbadevi Shamaldas Gandhi Marg Lohar Chawl, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2024, the company reported a revenue of ₹18.91 Cr, a growth of 51% compared to the previous year. For the same year it recorded a net profit of ₹18.8 Lakh (net margin 1%) and EBITDA of ₹25.39 Lakh (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 130% over five years.
Company details
Contact details
Honeybell Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address82/90 Ground Floor Anandbhavan Kalbadevi Shamaldas Gandhi Marg Lohar Chawl, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Honeybell Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Honeybell Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Honeybell Pharma Private Limited, buy the company report.
Financials of Honeybell Pharma Private Limited
FY 2025 filings availableHoneybell Pharma Private Limited reported revenue of ₹18.91 Cr (up 51% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 130% over five years, including 51% growth in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Honeybell Pharma Private Limited, buy the company report.
Board of directors of Honeybell Pharma Private Limited
Honeybell Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankit Kumar Lalit Kumar Jain | Additional Director | 29 Sep 2020 | 6 Years 1 Months | Current |
| Bhavesh Prakash Jain Also directs: Gmsanjivani LLP, American Remedies Healthcare Private Limited | Director | 12 Nov 2018 | 7 Years 11 Months | Current |
| Sanjay Sampatraj Parekh | Additional Director | 01 Apr 2020 | 6 Years 7 Months | Current |
Auditor
Honeybell Pharma Private Limited is audited by DHAWAN & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHAWAN & CO | FY 2020 | 002864N |
Shareholding
The shareholding of Honeybell Pharma Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Honeybell Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Honeybell Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Honeybell Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Honeybell Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECH7108M1ZB | Maharashtra | Active | 01 Feb 2019 |
To see the full GST registrations and return filing status of Honeybell Pharma Private Limited, buy the company report.
Recent activity
Honeybell Pharma Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Ankit Kumar Lalit Kumar Jain was appointed as Additional Director on 29 Sep 2020.
Frequently asked questions
Honeybell Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 November 2018 (8+ years old) and is registered under CIN U74999MH2018PTC316948.
Honeybell Pharma has 3 current directors:
- Ankit Kumar Lalit Kumar Jain - Additional Director
- Bhavesh Prakash Jain - Director
- Sanjay Sampatraj Parekh - Additional Director
The latest financial statements of Honeybell Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Honeybell Pharma is 27AAECH7108M1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Honeybell Pharma is U74999MH2018PTC316948. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Honeybell Pharma was incorporated on 12 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Ankit Kumar Lalit Kumar Jain was appointed as Additional Director on 29 Sep 2020. Niravkumar Lalitkumar Jain ceased to be Director on 29 Sep 2020. Nayan Pravin Thakkar ceased to be Director on 01 Apr 2020. Honeybell Pharma has 5 board changes on record in total.
The registered office of Honeybell Pharma is at 8290 Ground Floor Anandbhavan Kalbadevi Shamaldas Gandhi Marg Lohar Chawl, Mumbai, Maharashtra, India – 400002.
Honeybell Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Honeybell Pharma can be reached at its registered office: 8290 Ground Floor Anandbhavan Kalbadevi Shamaldas Gandhi Marg Lohar Chawl, Mumbai, Maharashtra, India – 400002.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
